Company / PP&E (Net)
TREACE MEDICAL CONCEPTS, INC. PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$29.8M
FY2025
5-year range
$2.8M / $29.8M
FY2021-FY2025
Trend
+14.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has increased for 4 consecutive years, from $3M in FY2021 to $30M in FY2025.
Based on SEC 10-K filings.
$30M in FY2025 with a 3-year CAGR of +24.7%.
Improved from $22M to $30M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s pp&e (net) has grown for 4 consecutive years.
- 3-year CAGR of +24.7%, indicating consistent growth.
- In FY2025, pp&e (net) increased 14.6% year-over-year.
- Lowest pp&e (net) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.8M | +14.6% |
| FY2024 | $26.0M | +16.4% |
| FY2023 | $22.3M | +45.4% |
| FY2022 | $15.3M | +438.4% |
| FY2021 | $2.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026